|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Income/(loss) for the year | |||||
| Adjustments to reconcile income/(loss) for the period to net cash used in operating activities: | |||||
| Non-cash items: | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense | |||||
| (Gain)/loss on investment held at fair value | |||||
| Realized (gain)/loss on sale of investments | |||||
| Gain on dilution of ownership interest in associates | |||||
| Impairment of investment in associates | |||||
| Gain on deconsolidation of subsidiary | |||||
| Share of net (gain)/loss of associates accounted for using the equity method | |||||
| (Gain)/loss on investments in notes from associates | |||||
| Fair value gain on other financial instruments | |||||
| (Gain)/loss on disposal of assets | |||||
| Impairment of fixed assets | |||||
| Income taxes expense/(benefit) | |||||
| Finance (income)/costs, net | |||||
| Changes in operating assets and liabilities: | |||||
| Trade and other receivables | |||||
| Prepaid expenses and other financial assets | |||||
| Deferred revenue | |||||
| Trade and other payables | |||||
| Other | |||||
| Income taxes paid | |||||
| Interest received | |||||
| Interest paid | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of intangible assets | |||||
| Investment in preferred shares held at fair value | |||||
| Purchase of investments held at fair value | |||||
| Sale of investments held at fair value | |||||
| Purchase of short-term note from associate | |||||
| Investment in convertible notes from associates | |||||
| Short-term note to associate | |||||
| Repayment of short-term note from associate | |||||
| Cash derecognized upon loss of control over subsidiary | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturity of short-term investments | |||||
| Receipt of payment of sublease | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Receipts from Royalty Purchase Agreement | |||||
| Issuance of subsidiary preferred shares | |||||
| Issuance of Subsidiary Convertible Note | |||||
| Payment of lease liability | |||||
| Exercise of stock options | |||||
| Settlement of restricted stock unit equity awards | |||||
| Vesting of restricted stock units and net share exercise | |||||
| NCI exercise of stock options in subsidiary | |||||
| Repurchase of ordinary shares from Tender Offer, including associated costs | |||||
| Payments of withholding taxes in connection with stock-based awards | |||||
| Purchase of treasury stock | |||||
| Acquisition of a non-controlling Interest of a subsidiary | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of non-cash investment and financing activities: | |||||
| Purchase of intangible assets not yet paid in cash | |||||
| Cost associated with Tender Offer not yet paid in cash | |||||
| Settlement of restricted stock units through issuance of equity | |||||
| Purchase of property, plant and equipment against trade and other payables | |||||
| Leasehold improvements purchased through lease incentives (deducted from Right of Use Asset) | |||||
| Conversion of subsidiary convertible note into preferred share liabilities | |||||
| Conversion of note receivable from associate into preferred shares | |||||
Loading...